STANLEY T CROOKE Insider Trading $ISIS IONIS PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for STANLEY T CROOKE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STANLEY T CROOKE. STANLEY T CROOKE is Chairman & CEO in IONIS PHARMACEUTICALS INC ($ISIS) and Chairman and CEO in IONIS PHARMACEUTICALS INC ($ISIS) and Chairman, President, CEO in IONIS PHARMACEUTICALS INC ($ISIS) and Exec Chairman of the Board in IONIS PHARMACEUTICALS INC ($ISIS) and Executive Chairman of Board in IONIS PHARMACEUTICALS INC ($ISIS).
STANLEY T CROOKE in IONIS PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STANLEY T CROOKE: Exec Chairman of the Board, Executive Chairman of Board, Chairman & CEO, Chairman and CEO, Chairman, President, CEO
Holdings: 2,021 shares
Latest Transaction: Jan 28 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of STANLEY T CROOKE in IONIS PHARMACEUTICALS INC
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 500 | 3,625 | 3,562 | 3.1 K to 3.6 K (+16.33 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.05 | 500 | 26,025 | 3,062 | 3.6 K to 3.1 K (-14.04 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 500 | 3,625 | 3,562 | 3.1 K to 3.6 K (+16.33 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 51.45 | 500 | 25,725 | 3,062 | 3.6 K to 3.1 K (-14.04 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 500 | 3,625 | 3,562 | 3.1 K to 3.6 K (+16.33 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.50 | 5,000 | 262,500 | 38,014 | 43 K to 38 K (-11.62 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 5,000 | 73,450 | 43,014 | 38 K to 43 K (+13.15 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.05 | 5,000 | 260,250 | 38,014 | 43 K to 38 K (-11.62 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 5,000 | 73,450 | 43,014 | 38 K to 43 K (+13.15 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 51.45 | 5,000 | 257,250 | 38,014 | 43 K to 38 K (-11.62 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 5,000 | 73,450 | 43,014 | 38 K to 43 K (+13.15 %) |
| Jul 24 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 1,000 | 7,250 | 4,904 | |
| Jul 24 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 10,000 | 146,900 | 106,642 | |
| Jul 24 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 55.35 | 1,000 | 55,350 | 3,062 | 4.1 K to 3.1 K (-24.62 %) |
| Jul 24 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 1,000 | 7,250 | 4,062 | 3.1 K to 4.1 K (+32.66 %) |
| Jul 24 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 55.35 | 10,000 | 553,500 | 38,014 | 48 K to 38 K (-20.83 %) |
| Jul 24 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 10,000 | 146,900 | 48,014 | 38 K to 48 K (+26.31 %) |
| Jul 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 1,500 | 10,875 | 5,904 | |
| Jul 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 15,000 | 220,350 | 116,642 | |
| Jul 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.45 | 1,500 | 78,675 | 3,062 | 4.6 K to 3.1 K (-32.88 %) |
| Jul 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 1,500 | 10,875 | 4,562 | 3.1 K to 4.6 K (+48.99 %) |
| Jul 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.45 | 15,000 | 786,750 | 38,014 | 53 K to 38 K (-28.29 %) |
| Jul 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 15,000 | 220,350 | 53,014 | 38 K to 53 K (+39.46 %) |
| Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 1,500 | 10,875 | 7,404 | |
| Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 1,538 | 22,593 | 131,642 | |
| Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 13,462 | 97,600 | 0 | |
| Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.10 | 1,500 | 78,150 | 3,062 | 4.6 K to 3.1 K (-32.88 %) |
| Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 1,500 | 10,875 | 4,562 | 3.1 K to 4.6 K (+48.99 %) |
| Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.30 | 1,538 | 80,437 | 38,014 | 39.6 K to 38 K (-3.89 %) |
| Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 1,538 | 22,593 | 39,552 | 38 K to 39.6 K (+4.05 %) |
| Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.08 | 13,462 | 701,101 | 38,014 | 51.5 K to 38 K (-26.15 %) |
| Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 13,462 | 97,600 | 51,476 | 38 K to 51.5 K (+35.41 %) |
| Apr 27 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 1,500 | 10,875 | 8,904 | |
| Apr 27 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 15,000 | 108,750 | 13,462 | |
| Apr 27 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 47.81 | 1,500 | 71,715 | 3,062 | 4.6 K to 3.1 K (-32.88 %) |
| Apr 27 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 1,500 | 10,875 | 4,562 | 3.1 K to 4.6 K (+48.99 %) |
| Apr 27 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 47.81 | 15,000 | 717,150 | 38,014 | 53 K to 38 K (-28.29 %) |
| Apr 27 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 15,000 | 108,750 | 53,014 | 38 K to 53 K (+39.46 %) |
| Apr 21 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 500 | 3,625 | 10,404 | |
| Apr 21 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 5,000 | 36,250 | 28,462 | |
| Apr 21 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 43.25 | 500 | 21,625 | 3,062 | 3.6 K to 3.1 K (-14.04 %) |
| Apr 21 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 500 | 3,625 | 3,562 | 3.1 K to 3.6 K (+16.33 %) |
| Apr 21 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 43.25 | 5,000 | 216,250 | 38,014 | 43 K to 38 K (-11.62 %) |
| Apr 21 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 5,000 | 36,250 | 43,014 | 38 K to 43 K (+13.15 %) |
| Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 500 | 3,625 | 10,904 | |
| Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 500 | 5,145 | 0 | |
| Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 10,000 | 72,500 | 33,462 | |
| Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 1,000 | 10,290 | 500 | |
| Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 10,000 | 72,500 | 43,462 | |
| Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 41.30 | 500 | 20,650 | 3,062 | 3.6 K to 3.1 K (-14.04 %) |
| Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 500 | 3,625 | 3,562 | 3.1 K to 3.6 K (+16.33 %) |
| Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 41.30 | 500 | 20,650 | 3,062 | 3.6 K to 3.1 K (-14.04 %) |
| Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 500 | 5,145 | 3,562 | 3.1 K to 3.6 K (+16.33 %) |
| Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 41.30 | 10,000 | 413,000 | 38,014 | 48 K to 38 K (-20.83 %) |
| Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 10,000 | 72,500 | 48,014 | 38 K to 48 K (+26.31 %) |
| Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 40.07 | 1,000 | 40,070 | 3,062 | 4.1 K to 3.1 K (-24.62 %) |
| Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 1,000 | 10,290 | 4,062 | 3.1 K to 4.1 K (+32.66 %) |
| Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 40.07 | 10,000 | 400,700 | 38,014 | 48 K to 38 K (-20.83 %) |
| Apr 13 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 10,000 | 72,500 | 48,014 | 38 K to 48 K (+26.31 %) |
| Mar 06 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 1,100 | 11,319 | 1,500 | |
| Mar 06 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 11,000 | 79,750 | 53,462 | |
| Mar 06 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 51.05 | 1,100 | 56,155 | 3,062 | 4.2 K to 3.1 K (-26.43 %) |
| Mar 06 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 1,100 | 11,319 | 4,162 | 3.1 K to 4.2 K (+35.92 %) |
| Mar 06 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 51.05 | 11,000 | 561,550 | 38,014 | 49 K to 38 K (-22.44 %) |
| Mar 06 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 11,000 | 79,750 | 49,014 | 38 K to 49 K (+28.94 %) |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 334 | 0 | 999 | |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 363 | 0 | 724 | |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 354 | 0 | 354 | |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 416 | 0 | 0 | |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 8,133 | 0 | 24,397 | |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 6,875 | 0 | 13,750 | |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 7,812 | 0 | 7,812 | |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 5,547 | 0 | 0 | |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 0.00 | 2,692 | 0 | 2,692 | |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 0.00 | 27,168 | 0 | 27,168 | |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 46.29 | 131 | 6,064 | 3,062 | 3.2 K to 3.1 K (-4.10 %) |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 334 | 0 | 3,193 | 2.9 K to 3.2 K (+11.68 %) |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 46.29 | 142 | 6,573 | 2,859 | 3 K to 2.9 K (-4.73 %) |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 363 | 0 | 3,001 | 2.6 K to 3 K (+13.76 %) |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 46.29 | 139 | 6,434 | 2,638 | 2.8 K to 2.6 K (-5.01 %) |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 354 | 0 | 2,777 | 2.4 K to 2.8 K (+14.61 %) |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 46.29 | 163 | 7,545 | 2,423 | 2.6 K to 2.4 K (-6.30 %) |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 416 | 0 | 2,586 | 2.2 K to 2.6 K (+19.17 %) |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 46.29 | 4,410 | 204,139 | 38,014 | 42.4 K to 38 K (-10.40 %) |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 8,133 | 0 | 42,424 | 34.3 K to 42.4 K (+23.72 %) |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 46.29 | 3,728 | 172,569 | 34,291 | 38 K to 34.3 K (-9.81 %) |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 6,875 | 0 | 38,019 | 31.1 K to 38 K (+22.07 %) |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 46.29 | 4,236 | 196,080 | 31,144 | 35.4 K to 31.1 K (-11.97 %) |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 7,812 | 0 | 35,380 | 27.6 K to 35.4 K (+28.34 %) |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 46.29 | 3,008 | 139,237 | 27,568 | 30.6 K to 27.6 K (-9.84 %) |
| Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 5,547 | 0 | 30,576 | 25 K to 30.6 K (+22.16 %) |
| Jan 12 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 1,200 | 12,348 | 2,600 | |
| Jan 12 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 12,000 | 87,000 | 64,462 | |
| Jan 12 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 49.25 | 1,200 | 59,100 | 2,170 | 3.4 K to 2.2 K (-35.61 %) |
| Jan 12 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 1,200 | 12,348 | 3,370 | 2.2 K to 3.4 K (+55.30 %) |
| Jan 12 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 49.25 | 12,000 | 591,000 | 25,029 | 37 K to 25 K (-32.41 %) |
| Jan 12 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 12,000 | 87,000 | 37,029 | 25 K to 37 K (+47.94 %) |
| Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 700 | 7,203 | 3,800 | |
| Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 7,000 | 50,750 | 76,462 | |
| Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 1,000 | 10,290 | 4,500 | |
| Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 10,000 | 72,500 | 83,462 | |
| Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 47.34 | 16,157 | 764,872 | 16,157 | |
| Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 47.34 | 163,013 | 7,717,035 | 163,013 | |
| Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 50.10 | 700 | 35,070 | 2,170 | 2.9 K to 2.2 K (-24.39 %) |
| Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 700 | 7,203 | 2,870 | 2.2 K to 2.9 K (+32.26 %) |
| Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 50.10 | 7,000 | 350,700 | 25,029 | 32 K to 25 K (-21.86 %) |
| Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 7,000 | 50,750 | 32,029 | 25 K to 32 K (+27.97 %) |
| Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 48.80 | 500 | 24,400 | 2,170 | 2.7 K to 2.2 K (-18.73 %) |
| Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 500 | 5,145 | 2,670 | 2.2 K to 2.7 K (+23.04 %) |
| Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 47.30 | 500 | 23,650 | 2,170 | 2.7 K to 2.2 K (-18.73 %) |
| Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 500 | 5,145 | 2,670 | 2.2 K to 2.7 K (+23.04 %) |
| Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 48.80 | 5,000 | 244,000 | 25,029 | 30 K to 25 K (-16.65 %) |
| Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 5,000 | 36,250 | 30,029 | 25 K to 30 K (+19.98 %) |
| Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 47.30 | 5,000 | 236,500 | 25,029 | 30 K to 25 K (-16.65 %) |
| Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 5,000 | 36,250 | 30,029 | 25 K to 30 K (+19.98 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 1,000 | 10,290 | 5,500 | |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 10,000 | 72,500 | 93,462 | |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 2,000 | 20,580 | 6,500 | |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 3,741 | 27,122 | 103,462 | |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 16,259 | 167,305 | 0 | |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 42.22 | 1,000 | 42,220 | 2,170 | 3.2 K to 2.2 K (-31.55 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 1,000 | 10,290 | 3,170 | 2.2 K to 3.2 K (+46.08 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 40.23 | 10,000 | 402,300 | 25,029 | 35 K to 25 K (-28.55 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 10,000 | 72,500 | 35,029 | 25 K to 35 K (+39.95 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 37.25 | 1,000 | 37,250 | 2,170 | 3.2 K to 2.2 K (-31.55 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 1,000 | 10,290 | 3,170 | 2.2 K to 3.2 K (+46.08 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 35.10 | 1,000 | 35,100 | 2,170 | 3.2 K to 2.2 K (-31.55 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 1,000 | 10,290 | 3,170 | 2.2 K to 3.2 K (+46.08 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 37.50 | 3,741 | 140,288 | 25,029 | 28.8 K to 25 K (-13.00 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 3,741 | 27,122 | 28,770 | 25 K to 28.8 K (+14.95 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 37.10 | 6,259 | 232,209 | 25,029 | 31.3 K to 25 K (-20.00 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 6,259 | 64,405 | 31,288 | 25 K to 31.3 K (+25.01 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 35.55 | 10,000 | 355,500 | 25,029 | 35 K to 25 K (-28.55 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 10,000 | 102,900 | 35,029 | 25 K to 35 K (+39.95 %) |
| Oct 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 1,000 | 10,290 | 8,500 | |
| Oct 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 10,000 | 102,900 | 16,259 | |
| Oct 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 36.61 | 1,000 | 36,610 | 2,170 | 3.2 K to 2.2 K (-31.55 %) |
| Oct 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 1,000 | 10,290 | 3,170 | 2.2 K to 3.2 K (+46.08 %) |
| Oct 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 36.61 | 10,000 | 366,100 | 25,029 | 35 K to 25 K (-28.55 %) |
| Oct 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 10,000 | 102,900 | 35,029 | 25 K to 35 K (+39.95 %) |
| Sep 29 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 2,000 | 20,580 | 9,500 | |
| Sep 29 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 20,000 | 205,800 | 26,259 | |
| Sep 29 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 36.05 | 2,000 | 72,100 | 2,170 | 4.2 K to 2.2 K (-47.96 %) |
| Sep 29 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 2,000 | 20,580 | 4,170 | 2.2 K to 4.2 K (+92.17 %) |
| Sep 29 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 36.02 | 20,000 | 720,400 | 25,029 | 45 K to 25 K (-44.42 %) |
| Sep 29 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 20,000 | 205,800 | 45,029 | 25 K to 45 K (+79.91 %) |
| Sep 23 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 2,000 | 20,580 | 11,500 | |
| Sep 23 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 20,000 | 205,800 | 46,259 | |
| Sep 23 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 35.50 | 2,000 | 71,000 | 2,170 | 4.2 K to 2.2 K (-47.96 %) |
| Sep 23 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 2,000 | 20,580 | 4,170 | 2.2 K to 4.2 K (+92.17 %) |